SCHEMBL167005

SCHEMBL167005

CCCCC(CC)COC(=O)C(Cc1cc(OC)c(O)c(OC)c1)C(=O)OCC(CC)CCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
CYP3A4 P08684 4/20 0.46
CA2 P00918 1/20 0.46
LMNA P02545 3/20 0.45
TSHR P16473 3/20 0.45
TDP1 Q9NUW8 2/20 0.45
ATM Q13315 1/20 0.45
MAPK1 P28482 3/20 0.44
HSD17B10 Q99714 1/20 0.42
RECQL P46063 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
PRSS3 P35030 1/20 0.41
CYP2C9 P11712 1/20 0.41
LTA4H P09960 1/20 0.41
LDHA P00338 1/20 0.38
KDM4E B2RXH2 1/20 0.38
GAA P10253 1/20 0.38
PKM P14618 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20395691 1.00 ALDH1A1 (0.46) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL27802013 0.95 ALDH1A1 (0.44) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL490710 0.90 ALDH1A1 (0.46) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL20395678 0.89 ALDH1A1 (0.45) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL20395674 0.88 ALDH1A1 (0.44) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL490869 0.87 LMNA (0.48) ALDH1A1CYP3A4CA2LMNACYP2C9
SCHEMBL490714 0.87 LDHA (0.56) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL490976 0.86 LMNA (0.51) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL491043 0.86 TDP1 (0.52) ALDH1A1CYP3A4CA2LMNATSHR
SCHEMBL491008 0.85 LMNA (0.48) ALDH1A1CYP3A4CA2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 286 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4319884-B1 COSMETIC COMPOSITION COMPRISING HINOKITIOL UNILEVER IP HOLDINGS B V (NL) 2026-05-27 EP claimed
US-20240173228-A1 COSMETIC COMPOSITION COMPRISING HINOKITIOL CONOPCO, INC., D/B/A UNILEVER (US) 2024-05-30 US claimed
EP-4319884-A1 COSMETIC COMPOSITION COMPRISING HINOKITIOL Unilever IP Holdings B.V. (NL) 2024-02-14 EP claimed
WO-2022214370-A1 COSMETIC COMPOSITION COMPRISING HINOKITIOL UNILEVER IP HOLDINGS B.V. (NL) 2022-10-13 WO claimed
US-20180207080-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS MERCK PATENT GMBH (DE) 2018-07-26 US claimed
EP-3322400-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS Merck Patent GmbH (DE) 2018-05-23 EP claimed
WO-2017008877-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS MERCK PATENT GMBH (DE) 2017-01-19 WO claimed
EP-1871735-B1 ANTIOXIDANTS MERCK PATENT GMBH (DE) 2015-12-23 EP claimed
US-8268293-B2 Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives MERCK PATENT GMBH (DE) 2012-09-18 US claimed
US-8106233-B2 Applying di-2-ethylhexyl 4-hydroxy-3,5-dimethoxy-benzylmalonate; protective action against UV rays, oxidative stress on body cells, counters skin ageing MERCK PATENT GMBH (DE) 2012-01-31 US claimed
US-20080171004-A1 Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives MERCK PATENT GMBH (DE) 2008-07-17 US claimed
US-20080152603-A1 Antioxidants SUSONITY Commercial GmbH (DE) 2008-06-26 US claimed
EP-1871339-A1 UV PROTECTION Merck Patent GmbH (DE) 2008-01-02 EP claimed
WO-2006111234-A1 UV PROTECTION MERCK PATENT GMBH (DE) 2006-10-26 WO claimed
EP-4319884-B1 COSMETIC COMPOSITION COMPRISING HINOKITIOL UNILEVER IP HOLDINGS B V (NL) 2026-05-27 EP disclosed
EP-4233832-B1 TRANSPARENT SUNSCREEN COMPOSITION WITH HIGH UVA PROTECTION DERMCOS GMBH (DE) 2026-04-01 EP disclosed
EP-3592329-B1 USE OF COMPATIBLE SOLUTES SUSONITY Commercial GmbH (DE) 2026-02-18 EP disclosed
EP-1871339-A1 UV PROTECTION Merck Patent GmbH (DE) 2008-01-02 EP disclosed
WO-2006111234-A1 UV PROTECTION MERCK PATENT GMBH (DE) 2006-10-26 WO disclosed
WO-2006111233-A1 ANTIOXIDANTS MERCK PATENT GMBH (DE) 2006-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080152603-A1 Antioxidants GPX4, GPX1, CAT ALDH1A1 181/4885CYP3A4 392/4885CA2 1558/4885
US-20080171004-A1 Using compounds which do not themselves exhibit significant UV absorption in the UV-A or UV-B region, but are reactive under use conditions, such as 4-hydroxyphenylpropionic acid, or 2-ethylhexyl 4-hydroxy-3,5-dimethoxycinnamate, or polysiloxanes which contain benzylidenemalonic acid derivatives HPD, HAAO, UGT1A6 ALDH1A1 314/4885CYP3A4 63/4885CA2 2547/4885
US-20180207080-A1 COMPOSITIONS OF FLUORINATED SURFACTANTS AND ANTIOXIDANTS LPO, CAT, GPX4 ALDH1A1 1313/4885CYP3A4 2870/4885CA2 3386/4885
US-20240173228-A1 COSMETIC COMPOSITION COMPRISING HINOKITIOL MITF, SUV39H2, SUV39H1 ALDH1A1 1655/4885CYP3A4 1990/4885CA2 4553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.